Provided By GlobeNewswire
Last update: May 12, 2025
Multiple doses of APG808 resulted in rapid suppression of FeNO, a biomarker of Type 2 inflammation associated with exacerbations in asthma, with a robust maximal FeNO decrease from baseline of 53%
Read more at globenewswire.comNASDAQ:APGE (6/13/2025, 2:34:55 PM)
42.88
+1.02 (+2.44%)
Find more stocks in the Stock Screener